MARKSANS.NS
MARKSANS.NS
INE750C01026
MARKSANS PHARMA LIMITED
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 29.416.430.000 26.144.450.000
12.5%
Cost of Revenue 13.725.770.000 12.294.560.000
11.6%
Gross Profit 15.690.660.000 13.849.890.000
13.3%
10.537.530.000 9.292.690.000
13.4%
Operating Income 5.153.130.000 4.557.200.000
13.1%
Pretax Income 5.605.550.000 5.039.670.000
11.2%
Net Income Common Stockholders 4.179.000.000 3.805.750.000
9.8%
-- --
--
-- --
--
ende